Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLBKINOSHITA, Masako; IKEDA, Akio; BEGUM, Tahamina et al.Journal of the neurological sciences. 2007, Vol 263, Num 1-2, pp 44-48, issn 0022-510X, 5 p.Article

Clobazam Therapeutic Drug Monitoring: A Comprehensive Review of the Literature With Proposals to Improve Future StudiesDE LEON, Jose; SPINA, Edoardo; DIAZ, Francisco J et al.Therapeutic drug monitoring. 2013, Vol 35, Num 1, pp 30-47, issn 0163-4356, 18 p.Article

Simultaneous determination of clobazam and its major metabolite in human plasma by a rapid HPLC methodROUINI, Mohammadreza; ARDAKANI, Yalda H; HAKEMI, Lida et al.Journal of chromatography. B. 2005, Vol 823, Num 2, pp 167-171, issn 1570-0232, 5 p.Article

Long-Term Use of Clobazam in Lennox-Gastaut Syndrome: Experience in a Single Tertiary Epilepsy CenterEUN HYE LEE; YUM, Mi-Sun; CHOI, Hae-Won et al.Clinical neuropharmacology. 2013, Vol 36, Num 1, pp 4-7, issn 0362-5664, 4 p.Article

Hot water epilepsy clinical profile and treatment—A prospective studyMEGHANA, A; SINHA, S; SATHYAPRABHA, T. N et al.Epilepsy research. 2012, Vol 102, Num 3, pp 160-166, issn 0920-1211, 7 p.Article

Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazamCONTIN, Manuela; SANGIORGI, Simonetta; RIVA, Roberto et al.Therapeutic drug monitoring. 2002, Vol 24, Num 6, pp 737-741, issn 0163-4356, 5 p.Article

Intermittent clobazam prophylaxis in hot water epilepsy is safe and effective: A prospective studySATISHCHANDRA, P; DILIPKUMAR, S; SUBBAKRISHNA, D. K et al.Epilepsy research. 2014, Vol 108, Num 7, pp 1238-1242, issn 0920-1211, 5 p.Article

Low Risk of Development of Substance Dependence for Barbiturates and Clobazam Prescribed as Antiepileptic Drugs : Results from a Questionnaire StudyUHLMANN, Carmen; FRÖSCHER, Walter.CNS neuroscience & therapeutics (Print). 2009, Vol 15, Num 1, pp 24-31, issn 1755-5930, 8 p.Article

ESSAI CLINIQUE COOPERATIF DU CLOBAZAM EN MEDECINE INTERNEROGER F; BARDEAU B; MEMIN Y et al.1975; GAZ. MED. FR.; FR.; DA. 1975; VOL. 82; NO 39; PP. 4700-4705 (4P.)Article

Clobazam as a new antiepileptic drug and clorazepate dipotassium as an alternative antiepileptic drug in JapanSUGAI, Kenji.Epilepsia (Copenhagen). 2004, Vol 45, pp 20-25, issn 0013-9580, 6 p., SUP8Conference Paper

Randomized, phase III study results of clobazam in Lennox-Gastaut syndromeNG, Y. T; CONRY, J. A; DRUMMOND, R et al.Neurology. 2011, Vol 77, Num 15, pp 1473-1481, issn 0028-3878, 9 p.Article

Clobazam as add-on therapy for temporal lobe epilepsy and hippocampal sclerosisMONTENEGRO, Maria Augusta; MEILMAN FERREIRA, Claudio; CENDES, Fernando et al.Canadian journal of neurological sciences. 2005, Vol 32, Num 1, pp 93-96, issn 0317-1671, 4 p.Article

Clobazam in Refractory Childhood EpilepsyKALRA, Veena; SETH, Rachna; MISHRA, Devendra et al.Indian journal of pediatrics. 2010, Vol 77, Num 3, pp 263-266, issn 0019-5456, 4 p.Article

Intermittent clobazam therapy in febrile seizuresROSE, Winsley; KIRUBAKARAN, Chellam; SCOTT, Julius Xavier et al.Indian journal of pediatrics. 2005, Vol 72, Num 1, pp 31-33, issn 0019-5456, 3 p.Article

Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe⁺⁺⁺-induced epileptic ratsDOI, Taku; UEDA, Yuto; TOKUMARU, Jun et al.Molecular brain research. 2005, Vol 142, Num 2, pp 91-96, issn 0169-328X, 6 p.Article

PHARMACOLOGY OF CLOBAZAM. INTERNATIONAL SYMPOSIUM ON CLOBAZAM, UNIVERSITY OF YORK, APRIL 13-15, 1981HINDMARCH I ED; LAL H ED; STONIER PD ED et al.1982; DRUG DEV. RES.; ISSN 0272-4391; USA; DA. 1982; SUPPL. 1; 186 P.; BIBL. DISSEM.Conference Paper

ETUDE CLINIQUE D'UN ANXIOLYTIQUE LE CLOBAZAM* CHEZ L'ENFANTDE VILLARD R.1976; LYON MED.; FR.; DA. 1976; VOL. 235; NO 8; PP. 783-785; BIBL. 6 REF.Article

ANXIOLYTIQUE NOUVEAU, LE RU4723. ACTION SUR LE SOMMEIL DE NUIT ET LE NIVEAU DE PERFORMANCE AU REVEILLEYGONIE F; RETHORE A; YUCEYATAK F et al.1975; GAZ. MED. FR.; FR.; DA. 1975; VOL. 82; NO 11; PP. 1303-1310 (6P.)Article

Determination of Clobazam, Clorazepate, Flurazepam and Flunitrazepam in pharmaceutical preparationsBERZAS, J. J; CASTANEDA, G; PINILLA, M. J et al.Talanta (Oxford). 2002, Vol 57, Num 2, pp 333-341, issn 0039-9140Article

Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (ω) receptor agonists on defensive behaviors of miceGRIEBEL, G; PERRAULT, G; SANGER, D. J et al.Pharmacology, biochemistry and behavior. 1999, Vol 62, Num 4, pp 689-694, issn 0091-3057Article

Analysis of clobazam and its active metabolite norclobazam in plasma and serum using HPLC/DADAKERMAN, K. K.Scandinavian journal of clinical & laboratory investigation. 1996, Vol 56, Num 7, pp 609-614, issn 0036-5513Article

Optimised determination of clobazam in human plasma with extraction and high-performance liquid chromatography analysisBOLNER, A; TAGLIARO, F; LOMEO, A et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 750, Num 1, pp 177-180, issn 1387-2273Article

LE CLOBAZAM DANS LA PRISE EN CHARGE THERAPEUTIQUE DE L'OBESITEDEFONTAINE M.1979; VIE MED.; FRA; DA. 1979; VOL. 60; NO 27; PP. 2444-2448; (3 P.)Article

A PROPOS D'UNE ETUDE SUR LE CLOBAZAM EN MEDECINE INTERNEPLAUCHU M; NAVARRO D.1975; J. MED. LYON; FR.; DA. 1975; VOL. 56; NO 1287; PP. 511-513Article

ETUDE D'UN ANXIOLYTIQUE CLOBAZAM EN O.R.L. DANS LES MANIFESTATIONS PSYCHOSOMATIQUES PHARYNGEESFRECHE C.1975; SEM. HOP., THERAPEUT.; FR.; DA. 1975; VOL. 51; NO 4; PP. 261-263Article